CARB-X awards $1M seed funding for Exhalon’s breath-based lower respiratory tract infection test
CARB-X awards $1M seed funding for Exhalon’s breath-based lower respiratory tract infection test
We use cookies to ensure that we give you the best experience on our website. Please visit carb-x.org/legal/ for more information. By clicking “Ok”, you consent to the use of all cookies.
Toggle navigation